S4 Ep10: Recommendations for Treating Central Nervous Systems Cancers
Craig Horbinski, MD, PhD, unpacks the NCCN Clinical Practice Guidelines for central nervous system tumors.
8m Jul 14, 2023
8m
S4 Ep9: Mitigating Cardiotoxicity Resulting from Immune Checkpoint Inhibitor Therapy
In season 4, episode 9 of Targeted Talks, Kerry Reynolds, MD of Massachusetts General Hospital discusses the occurrence of myocarditis in patients with cancer treated with immune checkpoint inhibitors.
13m Jun 30, 2023
13m
S4 Ep8: Pushing Forward With Molecularly-Driven Precision Medicine in Endometrial Cancer
An interview with Ruchi Garg, MD of City of Hope.
21m Jun 23, 2023
21m
S4 Ep7: Exciting Activity in Chronic Lymphocytic Leukemia
8m May 31, 2023
8m
S4 Ep6: Anticipating Novel Treatments for the RAI-Refractory DTC Armamentarium
An interview with Warren Swegal, MD.
9m May 15, 2023
9m
S4 Ep5: Advancing the Treatment of Alveolar Soft Part Sarcoma
An interview with Alice P. Chen, MD of the National Cancer Institute.
13m Apr 26, 2023
13m
S4 Ep4: Understanding and Treating Mucosal Melanoma
Richard D. Carvajal, MD, discusses mucosal melanoma and treatment options for the disease.
12m Apr 14, 2023
12m
S4 Ep3: Hitting New Targets in Metastatic Prostate Cancer
In season 4, episode 3 of Targeted Talks, Pedro Barata, MD, MSc, discusses the present and future of prostate cancer precision medicine.
13m Mar 16, 2023
13m
S4 Ep2: The Importance of Trastuzumab Deruxtecan in HER2+ Breast Cancer Treatment
A talk with Sara A. Hurvitz, MD about advances in the HER2-positive breast cancer space.
10m Feb 28, 2023
10m
S4 Ep1: Unpacking the Latest Research in Gastrointestinal Cancers
In season 4, episode 1 of Targeted Talks, Benjamin L. Schlechter, MD, of Dana-Farber Cancer Institute discuses new studies in gastrointestinal malignancies.
18m Feb 15, 2023
18m
S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment
In season 3, episode 10 of Targeted Talks, Nitika Sharma, MD of Cancer Treatment Centers of America, discusses FDA-approved and promising novel therapies for the treatment of small cell lung cancer.
21m Nov 17, 2022
21m
S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment
In season 3, episode 10 of Targeted Talks, Nitika Sharma, MD of Cancer Treatment Centers of America Atlanta, discusses FDA-approved and promising novel therapies for the treatment of small cell lung cancer.
21m Nov 17, 2022
21m
S3 Ep9: Special Episode: Managing Cardiotoxicity from ICI Therapy in Patients with Cancer
In season 3, episode 9 of Targeted Talks, Mohammed Salhab, MD, Chris Fine, MD, FACC, cardiologist at National Jewish Health, have a special discussion about cardiotoxicity from immune checkpoint inhibitor therapy in patients with cancer.
18m Oct 25, 2022
18m
S3 Ep8: Treating HER2-Positive Beast Cancer in the Community Setting
In season 3, episode 8 of Targeted Talks, Christie J. Hilton, DO, discusses treating first- and second-line HER2-positive breast cancer.
17m Sep 16, 2022
17m
S3 Ep7: The Evolution of Endometrial Cancer Treatment
In season 3, episode 7 of Targeted Talks, John Nakayama, MD, a gynecologic oncologist at Allegheny Health Network, discusses updates in the endometrial cancer treatment landscape.
10m Aug 15, 2022
10m
S3 Ep6: Examining the Non-Hodgkin Lymphoma Treatment Paradigm
Yazan Samhouri, MD, discusses the exciting new agents for the treatment of non-Hodgkin lymphoma, the clinical trials that support their use, and hopes for the future of treatment.
13m Jul 15, 2022
13m
S3 Ep5: The Road to Improving Diffuse Large B-Cell Lymphoma Treatment
In season 3, episode 5 of Targeted Talks, Thomas Habermann, MD, discusses the latest advances in the treatment of diffuse large B-cell lymphoma.
9m Jun 15, 2022
9m
S3 Ep4: Better Strategies for the Treatment of High-Risk Chronic Lymphocytic Leukemia
In season 3, episode 4 of Targeted Talks, Alexey Danilov, MD, PhD, discusses the shift toward utilizing cellular therapy to treat high-risk patients with chronic lymphocytic leukemia.
11m May 17, 2022
11m
S3 Ep3: Unpacking the New Recommendations for Early-Stage Breast Cancer Management
In season 3, episode 3 of Targeted Talks, William J. Gradishar, MD, discusses the latest version of the NCCN Clinical Practice Guidelines for managing early-stage breast cancer.
13m Apr 15, 2022
13m
S3 Ep2: Advances and Pending Innovations in the Treatment of Sarcoma
Mark Agulnik, MD, City of Hope Comprehensive Cancer Center joins Targeted Oncology for a discussion about the sarcoma treatment landscape and pending innovations under investigation in clinical trials.
19m Mar 16, 2022
19m
S3 Ep1: A Look Inside the Toolbox for BRAF-Mutant Metastatic Melanoma
In season 3, episode 1 of Targeted Talks, Michael A. Postow, MD, discusses available targeted agents for BRAF-mutant melanoma and ongoing clinical questions about treating the disease.
9m Feb 15, 2022
9m
S2 Ep10: Treating Sarcoma With a Multidisciplinary Approach
Sandra P. D'Angelo, MD of Memorial Sloan Kettering Cancer Center and Katherine Poruk, MD of Cancer Treatment Center of America discuss surgical and systemic treatment options for sarcoma.
17m Dec 15, 2021
17m
S2 Ep9: Sequencing Therapy for Metastatic Castration-Resistant Prostate Cancer
In season 2, episode 9 of Targeted Talks, Sandy Srinivas, MD and Nicholas J. Vogelzang, MD, discuss he optimal sequencing of therapies for a specific patient with metastatic castration-resistant prostate cancer.
18m Nov 17, 2021
18m
S2 Ep8: New Targeted Therapies in Renal Cell Carcinoma
In season 2, episode 8 of “Targeted Talks,” Thomas Hutson, DO, PharmD, and Rana R. McKay, MD, of UC San Diego Health, discussed the renal cell carcinoma paradigm and challenges to overcome in the future.
41m Sep 15, 2021
41m
S2 Ep7: Recent Developments in Immunotherapy for Melanoma
In season 2, episode 8 of Targeted Talks, Jeff Yorio, MD, and Douglas Johnson, MD, MSCI, joins us for a talk around recent advances in immunotherapy for melanoma.
24m Aug 16, 2021
24m
S2 Ep6: Special Episode: Insight on Targeting Rare Genomic Alterations in Colorectal Cancer
In season 2, episode 6 of Targeted Talks, Dr. Michael J. Overman joins us for a special discussion around rare genomic alterations in colorectal cancer.
16m Jul 15, 2021
16m
S2 Ep5: Advancing the Treatment of Cervical and Endometrial Cancers
In season 2, episode 6 of Targeted Talks, Alexander B. Olawaiye, MD leads a discussion with Haider S. Mahdi, MD, about the modern approaches to treating cervical and endometrial cancers.
33m Jun 15, 2021
33m
S2 Ep4: Special Episode: Oncology After COVID-19
In season 2, episode 4 of Targeted Talks, Benjamin O. Anderson, MD, FACS, discussed the lessons learned from the COVID-19 pandemic, and preparation for a post-COVID America.
9m May 14, 2021
9m
S2 Ep3: Modern Strategies Improving Immunotherapy in Cancer
Jason Luke, MD, leads a discussion with Sandip Patel, MD, about the present and future of immunotherapy in cancer.
29m Apr 15, 2021
29m
S2 Ep2: The Impact of the Gut Microbiome in Young Patients With Colorectal Cancer
Cathy Eng, MD and Benjamin Weinberg, MD discuss the gut microbiome and how it impacts young patients with colorectal. They also discuss the potential to use gut microbiome test to inform diagnosis, treatment, and monitoring of patients.
33m Feb 15, 2021
33m
S2 Ep1: Therapies on the Horizon in EGFR Exon 20–Positive Lung Cancer
Nagashree Seetharamu, MD and with Luis E. Raez, MD discuss the evolving treatment landscape of EGFR exon 20–mutated lung cancer.
28m Jan 15, 2021
28m
S1 Ep5: COVID-19 Leaves Its Mark on Oncology Care
Debra Patt, MD, PhD, MBA, speaks with Alex Spira, MD, PhD, FACP, about the impact of the COVID-19 pandemic on community cancer centers and hospitals in the United States
26m Dec 17, 2020
26m
S1 Ep4: Prostate Cancer Sees Surge of PARP Inhibition Strategies
In season 1, episode 4 of Targeted Talks, Michael Schweizer, MD, associate professor. Clinical Research Division, Fred Hutchinson Cancer Research Center, spoke with fellow oncologist, Winston Tan, MD, medical oncologist and professor of medicine, Mayo Clinic, about the ever-changing treatment landscape for prostate cancer.
24m Oct 15, 2020
24m
S1 Ep3: Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion with Stephanie Graff, MD, and Gabriel N. Hortobagyi, MD, FACP.
28m Sep 25, 2020
28m
S1 Ep2: Precision Medicine Guiding Ovarian Cancer Treatment
Sarah M. Temkin, MD leads a discussion with Daphne B. Stewart, MD, around targeted therapies in ovarian cancer, whether offered in the academic or community setting.
39m Jul 15, 2020
39m
S1 Ep1: Individualizing Immunotherapy in Non–Small Cell Lung Cancer
A discussion on immunotherapy use in non–small cell lung cancer between community physician Jason William, MD, DABR and research physician George R. Simon, MD, FACP, FCCP.
37m Jun 15, 2020
37m